Astex Pharmaceuticals and Genentech collaborate in breast cancer
AI Briefing
- • Astex Pharmaceuticals collaborates with Genentech on breast cancer research and drug development.
- • Exclusive agreement covers worldwide research and licensing of small-molecule candidates.
- • Goal is to identify treatments with selective inhibitory activity for breast cancer patients.
Context
Astex Pharmaceuticals Ltd. has entered into a research collaboration and license agreement with Genentech Inc. The agreement is exclusive and worldwide, focusing on breast cancer treatments.
The collaboration aims to identify small-molecule drug candidates as potential treatments for breast cancer, with selective inhibitory activity.
Advertisement